Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/226357
Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
The presence of circulating plasma cells in patients with multiple myeloma is considered a marker for highly proliferative disease. In the study herein, the impact of circulating plasma cells assessed by cytology on survival of patients with multiple myeloma was analyzed. Wright-Giemsa stained peripheral blood smears of 482 patients with newly diagnosed myeloma or plasma cell leukemia were reviewed and patients were classified into 4 categories according to the percentage of circulating plasma cells: 0%, 1-4%, 5-20%, and plasma cell leukemia with the following frequencies: 382 (79.2%), 83 (17.2%), 12 (2.5%) and 5 (1.0%), respectively. Median overall survival according to the circulating plasma cells group was 47, 50, 6 and 14 months, respectively. At multivariate analysis, the presence of 5 to 20% circulating plasma cells was associated with a worse overall survival (relative risk 4.9, 95% CI 2.6-9.3) independently of age, creatinine, the Durie-Salmon system stage and the International Staging System (ISS) stage. Patients with ≥5% circulating plasma cells had lower platelet counts (median 86×109/L vs 214×109/L, P<0.0001) and higher bone marrow plasma cells (median 53% vs 36%, P=0.004). The presence of ≥5% circulating plasma cells in patients with multiple myeloma has a similar adverse prognostic impact as plasma cell leukemia.
Matèries
Matèries (anglès)
Citació
Citació
GRANELL, Miquel, CALVO, Xavier, GARCIA GUINON, Antoni, ESCODA, Lourdes, ABELLA, Eugènia, MARTINEZ, Clara mª, TEIXIDO, Montserrat, GIMENEZ, Mª teresa, SENÍN, Alicia, SANZ, Patricia, CAMPOY, Desirée, VICENT, Ana, ARENILLAS, Leonor, ROSIÑOL DACHS, Laura, SIERRA, Jorge, BLADÉ, J. (joan), FERNÁNDEZ DE LARREA RODRÍGUEZ, Carlos josé, GEMMAC (Grup per l'estudi del mieloma i l'amiloïdosi de Catalunya). Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition. _Haematologica_. 2017. Vol. 102, núm. 6, pàgs. 1099-1104. [consulta: 11 de febrer de 2026]. ISSN: 0390-6078. [Disponible a: https://hdl.handle.net/2445/226357]